Exact Sciences Trading Volume Drops 40 Percent to 385th Rank Despite Stock Price Surge

On May 5, 2025, Exact Sciences Corporation (EXAS) saw a significant drop in trading volume, with a total of 2.16 billion shares traded, marking a 40.1% decrease from the previous day. This decline placed EXAS at the 385th position in terms of trading volume for the day. Despite this, the stock price of EXAS has been on an upward trend, rising by 3.45% over the past four days, with a cumulative increase of 19.07%.

Analysts at RBC Capital have recently raised their price target for Exact Sciences, reflecting a positive outlook on the company's future performance. This adjustment comes as part of a broader trend of increased optimism among analysts regarding EXAS's prospects.

In addition to RBC Capital, Robert W. Baird has also boosted its price objective for EXAS, indicating a growing consensus among financial experts about the stock's potential. The new target price set by Baird is $72.00, which is higher than the previous estimate of $69.00. This revision underscores the confidence that analysts have in the company's ability to deliver strong results in the coming months.

Furthermore, Royal Bank of Canada has initiated coverage on Exact Sciences, assigning a "sector perform" rating and a price target of $52.00. This move by RBC Capital adds to the growing list of analysts who are closely monitoring EXAS and providing insights into its future performance. The bank's rating suggests that while the stock may not outperform the broader market, it is still expected to deliver solid returns for investors.

Mizuho has also joined the ranks of analysts covering EXAS, assigning an "outperform" rating and a price target of $60.00. This rating indicates that Mizuho believes EXAS has the potential to outperform the broader market and deliver strong returns for investors. The price target set by Mizuho is slightly lower than the consensus target of $72.28, but it still reflects a positive outlook on the company's future performance.